24 results
424B5
STRO
Sutro Biopharma Inc
2 Apr 24
Prospectus supplement for primary offering
4:58pm
of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting … Executive Officer or our President, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our
424B5
STRO
Sutro Biopharma Inc
9 Feb 24
Prospectus supplement for primary offering
4:25pm
is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written consent … prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal
PRE 14A
5hrei gj4hi3
14 Apr 23
Preliminary proxy
4:05pm
POS AM
z0axt0u
28 Feb 22
Prospectus update (post-effective amendment)
5:46pm
POSASR
s3xlx
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
S-3ASR
gu9iolda0d46k8
2 Apr 21
Automatic shelf registration
4:59pm
424B5
m6nj0d1hf e70859pk2
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
ykvuc1dd6cksz9w
7 Dec 20
Prospectus supplement for primary offering
4:10pm
424B5
af7n3 8cwmza
12 May 20
Prospectus supplement for primary offering
5:02pm
424B5
7iybk
11 May 20
Prospectus supplement for primary offering
4:12pm
424B5
e3fvx64z4q4t914v
11 Oct 19
Prospectus supplement for primary offering
4:22pm
S-3
o09jykfqq2fduw5zrye9
4 Oct 19
Shelf registration
4:06pm
10-K
EX-3.1
f02mic0s3n 3j3lzyd
1 Apr 19
Annual report
12:00am
10-K
EX-3.2
v0vd3cw ktu6zaq
1 Apr 19
Annual report
12:00am